Clinical Decision Support
Routine blood panels carry a kidney-risk signal the creatinine threshold cannot see. One platform surfaces it, for the clinic and for research.
Cardio-kidney-metabolic health
Heart, kidney and metabolic disease are now treated as one connected syndrome (American Heart Association, 2023).
Kidneys
NephroSense reads kidney risk from routine labs already on file.
Heart
Kidney function is a required input to the American Heart Association’s heart-failure risk equations.
Circulation, 2024Blood vessels
CKD raises the risk of coronary disease, heart failure, arrhythmia and sudden cardiac death.
European Heart Journal, 2025Brain
Stroke risk rises as kidney function falls.
Nephrology Dialysis Transplantation, 2015Pancreas
Diabetes and high blood pressure are the two biggest causes of CKD.
CDCThe product
A risk band, a confidence signal and the next step, for physician review.
Kidney risk summary
Synthetic example
Innovation Track · DCI Network AI Conference 2026
Held at Harvard Medical School, Boston ·
“Directing the Test That Was Never Ordered: Pre-Specified Temporal Evaluation of a Case-Finding Model for Albuminuria in Adults With Preserved eGFR”
Awarded at
One platform, two channels
Health systems · current focus
CKD risk triage from the panel you already drew
Risk triage at the point of care.
For Clinicians, primary care groups, FQHCs
Biopharma research · second channel
Cohort construction for kidney and cardio-renal programs
Estimate the candidate population a site actually holds before you select it, rather than after.
How it works
Enter values or upload a lab report. No new tests, no new hardware.
With a confidence signal alongside, so the strength of the result is visible before you act.
Confirmatory testing and referral guidance, as a PDF or FHIR R4 summary, under physician review.
Latest
1 of 12 finalists
World Medical Innovation ForumBoston · 2026
Finalist · pitched live
Inaugural cohortTeam
Where our team trained
Logos reflect the education and past roles of our founders and advisors, and do not imply endorsement by these institutions.
Physician oversight required. NephroSense AI does not provide diagnoses and has not yet received FDA classification or clearance.
Advised by clinical, commercial and regulatory veterans. Meet the advisory board →
Start a conversation about a retrospective look-back, or try the clinical demo with built-in scenarios.
